• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Pharmaceutical Market
    Pharmaceutical News
    Pharmaceutical Stocks
    • Pharmaceutical Market
    • Pharmaceutical News
    • Pharmaceutical Stocks

    EPAM and Sinequa Partner to Solve Cognitive Search and Analytics Challenges in the Pharma Industry

    Investing News Network
    Sep. 12, 2016 09:56AM PST
    Pharmaceutical Investing

    EPAM Systems, Inc. (NYSE:EPAM) announced a partnership to deliver search and analytics solutions for data-driven Global 2000 companies in the pharmaceutical industry.

    EPAM Systems, Inc. (NYSE:EPAM), a leading global provider of product development and software engineering solutions, and Sinequa, a leader in Cognitive Search and Analytics and a founding sponsor of the Cognitive Computing Consortium, today announced a partnership to deliver search and analytics solutions for data-driven Global 2000 companies in the pharmaceutical industry. The combination of EPAM’s strong Big Data solutions practice and Sinequa’s unique Cognitive Search and Analytics platform offers customers the ability to gain quick, actionable insights from their structured and unstructured data.
    With the emphasis on Big Data, predictive capabilities and speed of insights continue to transform the Life Sciences industry. The partnership enables organizations, facing the common challenge of effectively leveraging valuable insights extracted from large and diverse silos of data, to improve collaboration and streamline business operations. Customers will benefit from EPAM’s extensive Big Data expertise and their experience developing innovative, search-based applications on top of Sinequa’s platform. The partnership also allows customers to leverage best-in-class capabilities provided by Sinequa, including Natural Language Processing, Machine Learning, text mining, and powerful semantic analysis.
    “As the Life Sciences industry continues to undergo unprecedented transformation to deliver more value-based and personalized medicine, the capability to integrate vast data resources and translate them into meaningful, actionable insights is critical,” said Richard Golob, Vice President, Global Head of Life Sciences, EPAM. “With that in mind, we are pleased to join Sinequa’s Partner Advantage Program, which will allow us to offer high-value solutions in areas of importance in Life Science R&D, as well as Big Data mining.”
    “Our clients believe that digital transformation relies mostly on making information available faster with contextual insight,” said Xavier Pornain, Vice President, WW Sales and Alliances, Sinequa. “EPAM brings experienced scientists and experts to implement and quickly customize our unique Cognitive Search and Analytics platform, allowing our customers to extract new and useful business insights from the vast quantities of available data.”
    About EPAM Systems
    EPAM Systems, Inc. (NYSE:EPAM), a leading global product development and platform engineering services company, is focused on delivering results through best-in-class software engineering, combined with innovative strategy, consulting and design capabilities. With 23 years of experience in the information technology industry, EPAM’s 18,000 people serve our customers in over 25 countries across North America, Europe, Asia and Australia. EPAM was ranked #8 in FORBES 25 Fastest Growing Public Tech Companies and ranked as a top information technology services company on FORTUNE’S 100 Fastest Growing Companies.
    For more information, please visit https://www.epam.com/ and follow us on Twitter (@EPAMSYSTEMS) and LinkedIn​.
    About Sinequa
    Recognized as a leader in the Gartner Magic Quadrant for Enterprise Search and other analysts’ reports, Sinequa provides a cognitive search and analytics platform for Fortune Global 2000 companies and government agencies. Using advanced Natural Language Processing (NLP) and Machine Learning algorithms, the solution offers insights extracted from structured and unstructured data. Millions of users in the world’s largest and most information-intensive organizations, including Airbus, AstraZeneca, Atos, Biogen, UCB, Credit Agricole, Mercer, and Siemens, rely on Sinequa to put business-critical information at the fingertips of their employees. Sinequa develops its expertise and its business around the world with a broad network of technology and business partners. Sinequa is a founding sponsor of the Cognitive Computing Consortium. For more information, https://www.sinequa.com.
    Forward-Looking Statements
    This press release includes statements which may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accuracy of which are necessarily subject to risks, uncertainties, and assumptions as to future events that may not prove to be accurate. Factors that could cause actual results to differ materially from those expressed or implied include general economic conditions and the factors discussed in our most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. EPAM undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities law.

    CONTACT: Danielle Ruess-Saltz
    M: 267.978.7688
    danielle_ruess-saltz@epam.com
    CONTACT: Erin Jones
    Avista PR for Sinequa
    704-664-2170
    ejones@avistapr.com
    pharmaceutical industryin the pharmaceutical industrylife sciences industryaustraliapersonalized medicineeuropebig data
    The Conversation (0)

    Go Deeper

    AI Powered
    Person using laptop with generative AI, ChatGPT and other symbols floating between them.

    12 Generative AI Stocks to Watch as ChatGPT Soars

    AI Outlook: World Edition

    AI Outlook: World Edition

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×